Novo Nordisk Inc. has recalled various sample-sized diabetes and weight loss medications, including Ozempic (semaglutide), Victoza (liraglutide), and multiple types of Tresiba and NovoLog insulin. These products were stored at temperatures below 32°F, which is outside of the required storage conditions. This temperature abuse can cause the medication to lose its effectiveness and can also physically damage the cartridges and pen-injectors. These products were distributed nationwide across the United States as clinical samples.
Storing these medications at freezing temperatures can alter the chemical structure of the drug, making it less effective or completely inactive, which could lead to poorly controlled blood sugar levels for patients. Additionally, the freezing process can cause the internal glass cartridges or the mechanical components of the pen-injectors to crack or fail, potentially leading to incorrect dosing or injury during use.
Healthcare provider consultation and product return
The batch numbers are printed on the product carton as indicated in the red box (e.g. the batch number is KP53230)
The red box shows where the batch number is located on the carton (e.g. the batch number is I2419A)
The batch numbers are also printed on the product. The red box shows where the batch number is located on the pen (e.g. the batch number is KP53230)
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.